patient
|
4 |
Age
|
62 |
Gender
|
male |
Origin
|
Germany |
Genotype
|
D |
PC_CP mutation
|
wt |
Weight(kg)
|
83 |
Duration of Pretreatment with Lamivudine (mo)
|
17 |
HBeAg Status at Baseline ADV
|
positive |
HBV DNA at Baseline ADV (log10 copies/mL)
|
7.13 |
Duration of ADV Therapy (mo)
|
18 |
HBV DNA at Baseline TDF (log10 copies/mL)
|
7.64 |